7322894283

Table 3 Clinical outcomes in post-treatment for participants with social anxiety disorder (SAD) assigned to cognitive-behavioural therapy (CBT) with in virtuo exposure, CBT with in vivo exposure or waiting-list conditions

	CBJ+in virtuo	CBJ+in vivo			ANOVA		Contrasts
	exposure. mean (s.d.) (0=17)	exposure. mean (s.d.) (n=22)	Waiting list. mean (s.d.) (n=20)	Condition, F(1.56)	Time, F0.56)	Interaction condition xtime, F{2,56)	Active treatments v. waiting list, « 56)	CBJ+in \/irtuo v. CBJ+in vivo exposure, f(56)
LSAS-SR Pre Post	85.1 (29.5) 51.8 (23.3)	74.9(24.5) 56.0 (26.9)	79.6 (24.9) 79.3 (22.0)	2.16	36.82***	10.42***	4.23***	2.02*
BAT Pre Post	5.9 (4.1) 8.4 (4.0)	5.4    (4.3) 8.5    (3.8)	6.9 (2.9) 7.3 (2.6)	0.02	23.79***^a	4.16*	2.78***^a	0.55
SPS Pre Post	39.0 (16.1) 19.2 (12.5)	30.9 (17.5) 22.4 (15.7)	33.4 (13.9) 38.9 (14.6)	3.2*	24.09* **^a	15.17** *^a	4.99***^a	2.69**^a
SIAS Pre Post	49.2 (17.6) 29.8 (13.9)	45.8 (16.9) 35.4 (17.4)	48.6    (13.4) 49.6    (10.2)	2.98	25.37***^a	9 13** *3	3 95***^a	1.90
FNE Pre Post	25.6 (5.5) 18.1 (8.5)	23.6 (6.0) 18.9(7.2)	24.5(4.8) 25.2 (4.5)	2.64	21.59***^a	8i2***^a	3.86** *^a	1.42
BDHI Pre Post	13.5 (9.4) 6.8 (9.8)	14.8 (13.1) 9.7 (11.1)	12.4    (6.9) 15.5    (11.9)	0.71	6.37^a	6.96**^a	3.72**^a	0.57

LSAS-SR. Liebowitz Social Anxiety Scalę; BAr, Befiavbr Avaidance Test* SPS. Social Phobia Scalę; StAS, Social interaction Anxiety Scalę; FNE, Fear of Negatwe Evaluatbn; BOI ll. Beck Depressbn inventory-ll.

a. Sągnificant when Bonferroni correct bn applied to the secondary outcome measures.

*P<0j05, **P<0.01. ***P<0.001.